Careteq Limited (ASX: CTQ) (“Careteq” or “the Company”), a clinical healthtech company delivering innovative and AI-enabled healthcare solutions, is pleased to release its full year results fro the period ending 30 June 2026 (“FY26”).
Careteq Limited (ASX: CTQ) (“Careteq” or “the Company”), a clinical healthtech company delivering innovative and AI-enabled healthcare solutions, is pleased to release its Annual Report for 2026.
Careteq Limited (ASX: CTQ) (“Careteq” or “the Company”), a clinical healthtech company delivering innovative and AI-enabled healthcare solutions, is pleased to announce the establishment of an Advisory Board to support the Company’s next phase of growth in its Home Medicines Review Referrals business (HMR Referrals). The Company is also pleased to announce the appointment of […]
Careteq Limited (ASX: CTQ) (“Careteq” or “the Company”), a clinical healthtech company delivering innovative and AI-enabled healthcare solutions, is pleased to provide the following quarterly update and commentary on its Appendix 4C for the quarter ending 30 June 2026.
Careteq Limited (ASX: CTQ) (Company) is pleased to announce that, following recent consultation with ASX regarding the Company’s operational plans, strategic objectives and proposed application of funds following the divestment of its wholly owned subsidiary, Embedded Health Solutions Pty Ltd (EHS) (EHS Disposal), ASX has confirmed that it will not suspend quotation of the Company’s […]
Careteq Limited (ASX: CTQ) (“Careteq” or “the Company”), a clinical healthtech company delivering innovative and AI-enabled healthcare solutions, is pleased to announce the appointment of Mr Leonard Math as a Non-Executive Director of the Company.
Careteq Limited (ASX: CTQ) (“Careteq” or “the Company”), is pleased to announce Completion of the sale of its fully owned subsidiary, Embedded Health Solutions (EHS) to Nationwide Investments Holdings Pty Ltd.
Careteq Limited (ASX: CTQ) (“Careteq” or “the Company”), advises that the General Meeting of Shareholders was held today at 9am (AEDT).
Careteq Limited (ASX: CTQ) (“Careteq” or “the Company”), a clinical healthtech company specialising in innovative medication management and clinical governance solutions, presents its 1HFY26 Appendix 4D and Half Year Report.
Careteq Limited (ASX: CTQ) (“Careteq” or “the Company”), a clinical healthtech company specialising in innovative medication management and clinical governance solutions, is pleased to announce it has entered into a binding sale agreement (SA) to divest its fully owned subsidiary, Embedded Health Solutions (EHS) to Nationwide Investments Holdings Pty Ltd (ACN: 664 833 970) (NIH).